A selection of major announcements

1. Taobo: The total sales volume of the retail and wholesale business in the past fiscal quarter recorded a low growth of 20-30% year-on-year

$TOPSPORTS (06110.HK)$It said that in the fiscal quarter from March to May 2023, the total sales volume of the Group's retail and wholesale business achieved a low growth of 20-30% year-on-year. As of May 31, 2023, the gross sales area of direct-run stores decreased by 1.7% month-on-month and 6.5% year-on-year.

2. China Gas announced annual results, achieving revenue of about HK$91,988 billion, up 4.3% year on year

$CHINA GAS HOLD (00384.HK)$:The annual results for the year ended March 2023 achieved revenue of HK$91,988 billion, up 4.3% year on year; net profit attributable to shareholders was HK$4.293 billion, down 44% year on year. It is mainly affected by the epidemic in many places and the slowdown in real estate development. During the period, the Group's total gas sales volume was 39.25 billion cubic meters, an increase of 6.9% over the previous year.

3. New World Development and New Founding Group: Chow Tai ?$#@$ made a voluntary full cash offer to New Creation Group and resumed trading on June 27

$NEW WORLD DEV (00017.HK)$and$NWS HOLDINGS (00659.HK)$According to the joint announcement, the offeror Century Acquisition Limited (a wholly-owned subsidiary of Chow Tai ?$#@$ Enterprise) has determined that it intends to submit a conditional voluntary full cash offer on the premise that pre-conditions are met or exempted (if applicable) to acquire all newly issued shares of Chow Tai Fu Holding Group has not yet beneficially held. For the avoidance of doubt, the newly created tender shares include the newly created shares already owned by New World Development Group and other co-actors of the offeror (with the exception of Chow Tai ?$#@$ Holding Group). However, each newly created share offered is HK$9.15 in cash.

4. Shiyao Group: The first domestic anti-GFRAL monoclonal antibody JMT203 was approved for clinical trials in China

$CSPC PHARMA (01093.HK)$It was announced that the antibody drug JMT203 independently developed by Shanghai Jinmante Biotechnology Co., Ltd., a subsidiary of the company, has been approved by China's State Drug Administration and can conduct clinical research in China. This product is a class 1 new drug independently developed by the Group to treat tumor malignancies. This product is an anti-GDNF family receptor protein (GFRAL) recombinant humanized monoclonal antibody that can effectively antagonize GDF15-GFRAL/RET signals, has appetite and metabolism regulation effects, and can potentially reverse or reduce malignant symptoms such as weight loss, anorexia, and muscle atrophy caused by tumors and chemotherapy drugs, thereby effectively improving the quality of life of cancer patients. Preclinical studies have shown that the product has good safety, can significantly inhibit weight loss in malignant mice, increase non-fasting blood sugar and foreclaw grip strength, thereby improving the tumor survival rate of malignant mice; in combination with antitumor therapy, it significantly increases treatment tolerability and prolongs survival. This product is the first anti-GFRAL antibody approved for clinical trials in China. Currently, GDF15 or GFRAL target drugs worldwide are in early clinical stages, and there are no marketed drugs yet. This product is expected to be an effective drug for treating tumor malignancies and has extremely high clinical development value.

5. L'Occitane: Group sales reached 2.135 billion euros in FY2023

$L'OCCITANE (00973.HK)$It was announced that the Group's sales exceeded the milestone of 2 billion euros in fiscal year 2023, reaching 2,135 billion euros, which is equivalent to an increase of 19.8% based on the reported exchange rate. Strong growth in FY2023 was driven by Soldejaneiro's outstanding performance and the steady growth of Elemis. The reported operating profit reached 239 million euros, a decrease of 23.0% from last year. The decrease was mainly due to the loss of value from two underperforming brands. On a management basis, that is, excluding the special effects of impairment, Russian divestment, and sharing losses of joint ventures, the operating profit for FY2023 reached 337 million euros, and the operating profit margin was 15.8%. The Board recommended a final dividend of €0.03129 per share, with a payout rate of 40%.

6. Tencent Holdings spent HK$401 million to buy back 1.2 million shares on June 26

$TENCENT (00700.HK)$It was announced on the Hong Kong Stock Exchange that 1.2 million shares will be repurchased on June 26 at a price of HK$330.4-338.8 per share, at a total cost of about HK$400 million.

Spin-off listing

China Liansu (02128.HK): Yida submits listing application to the Stock Exchange

Financial data

Asia Joint Infrastructure Holdings (00711.HK) annual net profit fell 13.86% to HK$105 million, final interest rate of HK1.05 cents

L'Occitane (00973.HK): Group sales reach 2.135 billion euros in FY2023

The annual net profit of Zhenxiong Group (00057.HK) fell 39% to HK$130 million, with a final interest rate of HK7.3 cents

Anwy Asia (00645.HK)'s annual loss of $829,000 narrowed by 61.04% year-on-year

Zhiqin Holdings (09913.HK) net profit of about HK$53.5 million in fiscal year 2023 increased by about 37.9% year-on-year

Guanya Commercial Group (00104.HK) annual net profit of HK$44 million decreased 48% year on year

Zhuojia Holdings (01827.HK)'s annual revenue increased 27.3% to HK$463 million with a net loss of approximately HK$20.5 million

The annual turnover of Bauhaus International (00483.HK) declined by approximately 21.1% to approximately HK$197 million

The annual turnover of Yongfa Real Estate (00287.HK) increased by about 1.7% year-on-year to about HK$19.24 million

Sales increased sharply from last year, with annual revenue of Asian Groceries (08413.HK) increasing 18.6% to HK$286 million

Wanjia Group (00401.HK) turned an annual loss into a profit of HK$1.82 million

KFM Kinder (03816.HK) turned an annual loss into a profit of HK$22.66 million

HYPEBEAST (00150.HK)'s annual profit to loss reached HK$5.1 million

The annual revenue of Guoneng International Assets (00918.HK) was about HK$213.7 million, up 3.1% year-on-year

Performance Forecast

Qiantang Holdings (01466.HK) Yingxi: Expected annual net profit of about HK$8.7 million to turn a year-on-year loss into a profit

Australian Supreme (02031.HK) Yingxi: Expected annual comprehensive profit of HK$100,000 to HK$1.2 million to turn a year-on-year loss into a profit

Junan Holdings (01559.HK): Expected annual net loss to around HK$110 million - HK$130 million

Jianhong Group Holdings (01557.HK) Profit Alert: Expected annual net loss to no more than HK$74.2 million

Green Economy (01315.HK): Expected annual net loss of about HK$85.3 million, loss increased by about HK$71.1 million year-on-year

Acer Group Holdings (01718.HK) Profit Alert: Expected annual net loss of not less than HK$47 million

Gaoya Optics (00907.HK) expects an annual loss of about HK$50 million to narrow year-on-year

Kexuan Power Holdings (00476.HK) Profit Alert: Expected annual net loss of HK$78 million to HK$88 million

Operational data

Tao Bo (06110.HK): The total sales amount of retail and wholesale business in the first quarter recorded a low of 20-30% year-on-year increase

Bay Area Development (00737.HK): The total toll revenue of the Guangzhou-Shenzhen Expressway in May was 244 million yuan, up 21% year-on-year

Mergers and acquisitions

Xiehe New Energy (0018.2.HK) plans to purchase wind power equipment for 354 million yuan

Conoa-B (02162.HK) plans to acquire the remaining shares of Chengdu Connolco Bank for 151 million yuan

TimeGibao (02033.HK) plans to sell yacht assets for $5.3 million

Jinma Energy (06885.HK) plans to acquire 10% of Jinrui Energy's shares for 20 million yuan

Baoxin Real Estate (00299.HK) plans to sell all shares of Shenzhen Saiao Enterprise Management for 10,000 yuan

Issuance of additional shares

China Tiangong Holdings (00428.HK) plans to discount about 16.67% and place a maximum of 86.334 million shares, net funding of HK$17.1 million

Investment and operation

Changfei Optical Fiber Cable (06869.HK): Changfei Advanced Semiconductor plans to raise a total of about 6 billion yuan through debt financing and equity financing

Green Bamboo Bio-B (02480.HK) and Rep Biotech sign a strategic cooperation framework agreement

Beautiful Tianyuan Healthcare (02373.HK) signed a strategic cooperation framework agreement to explore new project research and development and seek cooperation opportunities in the fields of medical aesthetics and healthcare

Fuhong Hanlin (02696.HK): Clinical trial application for ipimumab antibiotic analogue HLX13 (recombinant anti-CTLA-4 whole-person monoclonal antibody injection) for liver cancer treatment was approved by the State Drug Administration

Australian Energy Construction (01183.HK) signs electric vehicle charging contract

Stone Pharmaceutical Group (01093.HK): Marketing application for injectable omazumab accepted by the State Drug Administration

CPC Pharmaceutical Group (01093.HK): Tetazolamide phosphate for injection received drug registration approval

Repurchase news

Tencent Holdings (00700.HK) spent HK$401 million to buy back 1.2 million shares on June 26

Changshi Group (01113.HK) spent HK$43,013 million to buy back 992,000 shares on June 26

Xiaomi Group-W (01810.HK) spent HK$24.1224 million to buy back 2.3 million shares on June 26

AIA (01299HK) spent HK$132 million to repurchase 1,713,800 shares on June 26

Mengniu Dairy (02319.HK) spent HK$7.503 million to buy back 250,000 shares on June 26

HSBC Holdings (00005.HK) spent HK$150.5 million to buy back 2.5 million shares on June 23

Haier Smart Home (06690.HK) spent 259.585 million yuan on June 26 to buy back 1,1192 million A-shares

Jinke Services (09666.HK) spent HK$3,079,900 to repurchase 300,000 shares on June 26

Standard Chartered Group (02888.HK) spent 2.39 million pounds on June 23 to buy back 363,000 shares

Equity incentives

Vitamin Milk International (00345.HK) granted a total of 3.164,000 shares to purchase shares and a total of 1,643 million restricted share units

Times Group Holdings (01023.HK) awarded a total of 13.6 million share awards

Prussia Group Holdings (02486.HK) Adopts Share Award Scheme

Appointments and dismissals

JD Group-SW (09618.HK): JD Logistics Appoints Hu Wei as CEO

edit/lambor